Management of haemophilia and its complications in developing countries.
Eighty per cent of people with haemophilia live in developing countries, where technical expertise and health care facilities may be less than optimal. Haemophilia is a relatively rare disease and high-cost, technology-intensive therapy is not a high priority for the governments of developing countries. The rapid spread of transfusion-related viral infections in many developing countries presents further problems for haemophiliacs. However, it is possible to manage haemophiliacs patients with limited resources. Strategies for conserving factor concentrates, include education of doctors and patients, prenatal diagnosis, increasing the use of anti-fibrinolytic agents, physiotherapy, the use of fibrin glue, and simple orthotics and prosthetic measures. These approaches are helpful in the majority of these patients. Meanwhile, with the help of the World Federation of Haemophilia (WFH), all developing countries are gradually improving management skills for this relatively rare but disabling disease. The present review broadly describes the management of various aspects of severe haemophilia in developing countries.
Ghosh
K
K
Institute of Immunohaematology, KEM Hospital, Parel, Mumbai, India. kanjakshaghosh@hotmail.com
D003906:Developing Countries; D019468:Disease Management; D006467:Hemophilia A / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D007390:International Agencies